Sanara MedTech Inc. - 8-K Filing

Sanara MedTech reports Q3 2026 net revenue of $28.4 million, an 8% increase YoY, despite a net loss of $1.3 million due to merger-related costs. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 12, 2026, 21:10 UTC

Tickers: $SMTI

Read the full article at SEC EDGAR

Part of the story Equillium, Inc. - 8-K Filing (3 articles)

More Regulatory news

SEMPRA - 8-K Filing SEC EDGAR · November 12, 2026, 21:16 UTC
MultiSensor AI Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:16 UTC
VICI PROPERTIES INC. - 8-K Filing SEC EDGAR · November 12, 2026, 21:16 UTC
ANAPTYSBIO, INC - 8-K Filing SEC EDGAR · November 12, 2026, 21:16 UTC
Tenon Medical, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:15 UTC
AmpliTech Group, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:16 UTC
Ardent Health, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:16 UTC
Energous Corp - 8-K Filing SEC EDGAR · November 12, 2026, 21:16 UTC
ASSEMBLY BIOSCIENCES, INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:15 UTC
ARC Group Acquisition I Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:15 UTC